Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 11, 2011 - Issue 4
Submit an article Journal homepage
84
Views
9
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Minimal residual disease testing to predict relapse following transplant for AML and high-grade myelodysplastic syndromes

Gerald B Wertheim Department of Pathology and Laboratory Medicine, University of Pennsylvania, 7103 Founders Pavilion, 3400 Spruce Street, Philadelphia, PA 19104-4283, USA; Department of Pathology and Laboratory Medicine, University of Pennsylvania, 7103 Founders Pavilion, 3400 Spruce Street, Philadelphia, PA 19104-4283, USA
&
Adam Bagg Department of Pathology and Laboratory Medicine, University of Pennsylvania, 7103 Founders Pavilion, 3400 Spruce Street, Philadelphia, PA 19104-4283, USA;[email protected]
Pages 361-366 | Published online: 09 Jan 2014

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Benjamin Tomlinson & Hillard M. Lazarus. (2017) Enhancing acute myeloid leukemia therapy - monitoring response using residual disease testing as a guide to therapeutic decision-making. Expert Review of Hematology 10:6, pages 563-574.
Read now
Ya-Zhen Qin, Hong-Hu Zhu, Yan-Rong Liu, Ya-Zhe Wang, Hong-Xia Shi, Yue-Yun Lai, Lan-Ping Xu, Dai-Hong Liu, Qian Jiang, Ling-Di Li, Bin Jiang, Kai-Yan Liu & Xiao-Jun Huang. (2013) PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes. Leukemia & Lymphoma 54:7, pages 1442-1449.
Read now

Articles from other publishers (7)

L H Xie, M Biondo, S J Busfield, A Arruda, X Yang, G Vairo & M D Minden. (2017) CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission. Blood Cancer Journal 7:6, pages e567-e567.
Crossref
Chen-Hua Yan, Qi-fa Liu, De-pei Wu, Xi Zhang, Lan-Ping Xu, Xiao-hui Zhang, Yu Wang, He Huang, Hai Bai, Fen Huang, Xiao Ma & Xiao-Jun Huang. (2017) Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease–Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed Acute Leukemia. Biology of Blood and Marrow Transplantation.
Crossref
Chen-Hua Yan, Yu Wang, Jing-Zhi Wang, Yu-Hong Chen, Yao Chen, Feng-rong Wang, Yu-Qian Sun, Xiao-Dong Mo, Wei Han, Huan Chen, Xiao-hui Zhang, Lan-Ping Xu, Kai-Yan Liu & Xiao-Jun Huang. (2016) Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant. Journal of Hematology & Oncology 9:1.
Crossref
Nikolai Nikolaevich Mamaev, Ya.V. Gudozhnikova & A.V. Gorbunova. (2016) WT1 Gene Overexpression in Oncohematological Disorders: Theoretical and Clinical Aspects (Literature Review). Clinical oncohematology 9:3, pages 257-264.
Crossref
Emily Bart-Smith & Ghulam J. Mufti. (2014) Allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes. Current Opinion in Oncology 26:6, pages 642-649.
Crossref
Monica S Thakar, Julie-An M Talano, Richard L Tower, Michael E Kelly & Michael J Burke. (2014) Indications for transplantation in childhood acute leukemia and the impact of minimal residual disease on relapse: a review. Clinical Practice 11:1, pages 79-90.
Crossref
Todd A Braciak, Sarah Wildenhain, Claudia C Roskopf, Ingo A Schubert, Georg H Fey, Uwe Jacob, Karl-Peter Hopfner & Fuat S Oduncu. (2013) NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2. Journal of Translational Medicine 11:1, pages 289.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.